James J. Daniero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James J. Daniero has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Gelbard
Vanderbilt University Medical Center, Nashville
8 shared publications Alexander T. Hillel
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland
4 shared publicationsDale C. Ekbom
Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota
4 shared publications- James L. Netterville
Vanderbilt University Medical Center
4 shared publications - Matthew Scott Clary
Department of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado
4 shared publications Naushin Ali
Department of Otolaryngology—Head and Neck Surgery University of Virginia Charlottesville Virginia USA
4 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (6) , e70625
Correlating Laryngoscopic and Clinical Findings With Airway Intervention in Angioedema
Objective(s): To evaluate whether specific presenting symptoms and laryngoscopic subsite involvement in aerodigestive angioedema predict clinical severity, defined by airway intervention, hospital admission, and length of stay (LOS). A secondary objective was to assess the performance of a reduced symptom‐based model for predicting intubation. Methods: A retrospective cohort study was performed of adult patients presenting with aerodigestive angioedema at a single tertiary academic medical center between January 2013 and January 2023. Data were abstracted from electronic medical records. Presenting symptoms and laryngoscopic subsites of edema were recorded. The primary outcome was airway intervention. Secondary outcomes included hospital admission and LOS. Multivariable logistic regression and receiver operating characteristic (ROC) analysis were used to assess predictors of intubation. Results: Among 203 patients, 17 (8.4%) required intubation. Stridor (OR, 12.5; 95% CI, 2.1–73.5), odynophagia (OR, 7.6; 95% CI, 1.7–33.8), and tongue swelling (OR, 6.0; 95% CI, 1.7–20.5) were independently associated with intubation. Oropharyngeal involvement on flexible laryngoscopy was associated with a higher intubation rate (32.0% vs. 5.1%; p = 0.004) and longer LOS (mean, 4.5 vs. 2.3 days; p = 0.034). A reduced three‐variable symptom model (stridor, odynophagia, tongue swelling) demonstrated good discriminatory performance (AUC, 0.79; 95% CI, 0.67–0.91). Conclusions: Specific presenting symptoms and oropharyngeal edema are key predictors of airway compromise in angioedema. A symptom‐only triage criteria showed strong discriminatory performance and may aid real‐time decision‐making. Prospective validation is warranted to support clinical implementation. Level of Evidence: 3.
- 4 November 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (6) , e70625
Open AccessCorrelating Laryngoscopic and Clinical Findings With Airway Intervention in Angioedema
Objective(s): To evaluate whether specific presenting symptoms and laryngoscopic subsite involvement in aerodigestive angioedema predict clinical severity, defined by airway intervention, hospital admission, and length of stay (LOS). A secondary objective was to assess the performance of a reduced symptom‐based model for predicting intubation. Methods: A retrospective cohort study was performed of adult patients presenting with aerodigestive angioedema at a single tertiary academic medical center between January 2013 and January 2023. Data were abstracted from electronic medical records. Presenting symptoms and laryngoscopic subsites of edema were recorded. The primary outcome was airway intervention. Secondary outcomes included hospital admission and LOS. Multivariable logistic regression and receiver operating characteristic (ROC) analysis were used to assess predictors of intubation. Results: Among 203 patients, 17 (8.4%) required intubation. Stridor (OR, 12.5; 95% CI, 2.1–73.5), odynophagia (OR, 7.6; 95% CI, 1.7–33.8), and tongue swelling (OR, 6.0; 95% CI, 1.7–20.5) were independently associated with intubation. Oropharyngeal involvement on flexible laryngoscopy was associated with a higher intubation rate (32.0% vs. 5.1%; p = 0.004) and longer LOS (mean, 4.5 vs. 2.3 days; p = 0.034). A reduced three‐variable symptom model (stridor, odynophagia, tongue swelling) demonstrated good discriminatory performance (AUC, 0.79; 95% CI, 0.67–0.91). Conclusions: Specific presenting symptoms and oropharyngeal edema are key predictors of airway compromise in angioedema. A symptom‐only triage criteria showed strong discriminatory performance and may aid real‐time decision‐making. Prospective validation is warranted to support clinical implementation. Level of Evidence: 3.
- Open Access
- 12 October 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (5) , e70578
Evaluating the Efficacy of Chitosan‐ l ‐ DOPA MAP Gel for Acute Laryngeal Injury
Objectives: This study aimed to evaluate the efficacy of an innovative chitosan‐ l ‐DOPA‐modified microporous annealed particle (MAP) hydrogel in reducing fibrosis and enhancing healing in the treatment of Acute Laryngeal Injury (ALgI). Methods: Four experimental treatment groups: uninjured control, sham treated control (saline), nonbioactive MAP gel (sMAP), and Chitosan‐ l ‐DOPA MAP gel (dMAP2) were evaluated in a validated rabbit model of acute laryngeal injury, consisting of posterior glottis mucosal stripping and debridement followed by treatment at 14 days postinjury. At Days 4 and 14 posttreatment, histological evaluations were performed to evaluate the posterior glottic thickness (PGT), collagen content and type within the posterior glottis via immunofluorescence staining, glycosaminoglycan (GAG) content via Alcian blue staining, and collagen fiber orientation through picrosirius red staining. Results: At Day 4, the dMAP2 treatment performed similarly to the standard MAP gel, indicating a consistent inflammatory profile. Though at Day 14, the dMAP2 treated injuries demonstrated a significant increase in PGT compared to uninjured controls ( p < 0.001), the healing wound expressed a significant increase in collagen area, including collagen I, collagen III, and colocalized species ( p < 0.05). The alignment of collagen fibers within the tissue was consistent with the uninjured sample compared to the untreated injury. In a similar relationship, dMAP2 treated wounds led to similar GAG expression within the cricoarytenoid joint as the uninjured tissue, compared to the untreated injury consistent with a reduced arthritic condition. Conclusions: The dMAP2 gel improved healing with organized tissue remodeling compared to untreated controls through the proliferative phase of wound healing. Level of Evidence: 3
- 12 October 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (5) , e70578
Open AccessEvaluating the Efficacy of Chitosan‐ l ‐ DOPA MAP Gel for Acute Laryngeal Injury
Objectives: This study aimed to evaluate the efficacy of an innovative chitosan‐ l ‐DOPA‐modified microporous annealed particle (MAP) hydrogel in reducing fibrosis and enhancing healing in the treatment of Acute Laryngeal Injury (ALgI). Methods: Four experimental treatment groups: uninjured control, sham treated control (saline), nonbioactive MAP gel (sMAP), and Chitosan‐ l ‐DOPA MAP gel (dMAP2) were evaluated in a validated rabbit model of acute laryngeal injury, consisting of posterior glottis mucosal stripping and debridement followed by treatment at 14 days postinjury. At Days 4 and 14 posttreatment, histological evaluations were performed to evaluate the posterior glottic thickness (PGT), collagen content and type within the posterior glottis via immunofluorescence staining, glycosaminoglycan (GAG) content via Alcian blue staining, and collagen fiber orientation through picrosirius red staining. Results: At Day 4, the dMAP2 treatment performed similarly to the standard MAP gel, indicating a consistent inflammatory profile. Though at Day 14, the dMAP2 treated injuries demonstrated a significant increase in PGT compared to uninjured controls ( p < 0.001), the healing wound expressed a significant increase in collagen area, including collagen I, collagen III, and colocalized species ( p < 0.05). The alignment of collagen fibers within the tissue was consistent with the uninjured sample compared to the untreated injury. In a similar relationship, dMAP2 treated wounds led to similar GAG expression within the cricoarytenoid joint as the uninjured tissue, compared to the untreated injury consistent with a reduced arthritic condition. Conclusions: The dMAP2 gel improved healing with organized tissue remodeling compared to untreated controls through the proliferative phase of wound healing. Level of Evidence: 3
- Open Access
Voice Outcomes of Patients Intubated for Critical COVID Illness: A Multicenter Study
Objective: Characterize the long‐term vocal outcomes of patients who required ICU care for COVID‐19 infection. Study Design: Prospective cohort study. Setting: Multi‐institutional North American Airway Collaborative Study. Methods: Patients with a COVID‐19 diagnosis requiring ICU admission were identified via ICD‐10 codes and recruited after discharge to complete patient‐reported outcome measures (PROM) in voice (Voice Handicap Index: VHI‐10), communication (Communicative Participation Item Bank: CPIB), and breathing (Clinical COPD Questionnaire: CCQ). Multivariate analysis investigated the association between clinical variables and PROMs. Results: 308 patients enrolled; 271 were admitted with COVID to the ICU. 221 were intubated (81.5%); 50 patients admitted to the ICU did not require intubation (18.5%). Mean follow‐up was 489 days after discharge (95% CI: 452‐526). Mean intubation duration was 17 days (95% CI: 15‐19). Median endotracheal tube (ETT) size was 7.5. Intubation was associated with higher VHI‐10 score (15 vs 10; P = .01) and lower CPIB score (27 vs 30; P < .01). When controlling for ETT size, multivariate analysis did not show a relationship between intubation duration and VHI‐10 or CPIB scores but was associated with worse CCQ score ( P = .04). Conclusion: Survivors of COVID infection requiring ICU admission and intubation have persistent functional impairments in voicing and breathing more than 1 year after their hospitalization. While COVID survivorship and “long COVID” have centered on neuropsychiatric and metabolic outcomes, this study highlights the unappreciated negative impact of endotracheal intubation on voice and communication related to this illness and reinforces the relationship between duration of intubation and subjective dyspnea after surviving critical illness.
Open AccessVoice Outcomes of Patients Intubated for Critical COVID Illness: A Multicenter Study
Objective: Characterize the long‐term vocal outcomes of patients who required ICU care for COVID‐19 infection. Study Design: Prospective cohort study. Setting: Multi‐institutional North American Airway Collaborative Study. Methods: Patients with a COVID‐19 diagnosis requiring ICU admission were identified via ICD‐10 codes and recruited after discharge to complete patient‐reported outcome measures (PROM) in voice (Voice Handicap Index: VHI‐10), communication (Communicative Participation Item Bank: CPIB), and breathing (Clinical COPD Questionnaire: CCQ). Multivariate analysis investigated the association between clinical variables and PROMs. Results: 308 patients enrolled; 271 were admitted with COVID to the ICU. 221 were intubated (81.5%); 50 patients admitted to the ICU did not require intubation (18.5%). Mean follow‐up was 489 days after discharge (95% CI: 452‐526). Mean intubation duration was 17 days (95% CI: 15‐19). Median endotracheal tube (ETT) size was 7.5. Intubation was associated with higher VHI‐10 score (15 vs 10; P = .01) and lower CPIB score (27 vs 30; P < .01). When controlling for ETT size, multivariate analysis did not show a relationship between intubation duration and VHI‐10 or CPIB scores but was associated with worse CCQ score ( P = .04). Conclusion: Survivors of COVID infection requiring ICU admission and intubation have persistent functional impairments in voicing and breathing more than 1 year after their hospitalization. While COVID survivorship and “long COVID” have centered on neuropsychiatric and metabolic outcomes, this study highlights the unappreciated negative impact of endotracheal intubation on voice and communication related to this illness and reinforces the relationship between duration of intubation and subjective dyspnea after surviving critical illness.
- 23 March 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (8) , 3541-3547
Safety Profile in Hyaluronic Acid‐Based Vocal Fold Injection Augmentation
Objective: The study's objective is to assess the safety profile and complication rates of hyaluronic acid‐based vocal fold injection augmentation (VFIA), specifically evaluating inflammatory reactions, injection volume, and COVID‐19 vaccination status. Methods: A retrospective cohort study was conducted of 299 VFIA procedures performed using Restylane‐L at a single academic institution. Medical charts were reviewed to collect patient demographics, injection details (approach, location, and volume), videolaryngostroboscopy exams, and post‐injection outcomes, including complication rates and nature of inflammatory reactions. Results: The overall complication rate was 4.0% (12/299), with inflammatory complications comprising 2.34% (7/299) of cases. Inflammatory symptoms developed a mean of 4.3 days after injection (median: 3 days; range: 12 h–10 days) and resolved in all cases with corticosteroid therapy. A statistically significant difference in injection volume was noted among groups ( p = 0.037), although post hoc comparisons did not demonstrate significance. COVID‐19 vaccination status was not associated with complication rates ( p = 0.84). Conclusions: VFIA using HA‐based material demonstrates a low rate of complications, and all inflammatory reactions resolved with medical management. Injection volume may play a role in complication risk, but further multi‐site studies are needed. No association between COVID‐19 vaccination and adverse outcomes was identified. Level of Evidence: 3
- 23 March 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (8) , 3541-3547
Safety Profile in Hyaluronic Acid‐Based Vocal Fold Injection Augmentation
Objective: The study's objective is to assess the safety profile and complication rates of hyaluronic acid‐based vocal fold injection augmentation (VFIA), specifically evaluating inflammatory reactions, injection volume, and COVID‐19 vaccination status. Methods: A retrospective cohort study was conducted of 299 VFIA procedures performed using Restylane‐L at a single academic institution. Medical charts were reviewed to collect patient demographics, injection details (approach, location, and volume), videolaryngostroboscopy exams, and post‐injection outcomes, including complication rates and nature of inflammatory reactions. Results: The overall complication rate was 4.0% (12/299), with inflammatory complications comprising 2.34% (7/299) of cases. Inflammatory symptoms developed a mean of 4.3 days after injection (median: 3 days; range: 12 h–10 days) and resolved in all cases with corticosteroid therapy. A statistically significant difference in injection volume was noted among groups ( p = 0.037), although post hoc comparisons did not demonstrate significance. COVID‐19 vaccination status was not associated with complication rates ( p = 0.84). Conclusions: VFIA using HA‐based material demonstrates a low rate of complications, and all inflammatory reactions resolved with medical management. Injection volume may play a role in complication risk, but further multi‐site studies are needed. No association between COVID‐19 vaccination and adverse outcomes was identified. Level of Evidence: 3
- Open Access
- 5 November 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (6)
Development of a Clinically Relevant Rabbit Model of Acute Laryngeal Injury
Objectives: Acute laryngeal injury (ALgI) is created as a result of endotracheal tube pressure ulcer formation leading to fibrosis and inflammation. This condition often leads to airway obstruction and voice and swallowing dysfunction. This study demonstrates a reliable animal model of ALgI to reproduce the acute wound process seen clinically, to explore the pathophysiology of this disease process, and to serve as a reproducible injury suitable for the evaluation of therapeutic interventions. Methods: An ALgI model was developed in New Zealand White rabbits using precise mucosal stripping of the posterior larynx, followed by intubation with an oversized 4.0 endotracheal tube for 1 h to mimic intubation‐associated trauma and pressure ischemia. Laryngoscopy and laryngeal harvest were performed 2 weeks post‐injury for histologic and immunofluorescent evaluation. Results: Injured rabbits demonstrated an eightfold increase in posterior glottic thickness (1.57 vs. 0.19 mm in controls; p = 0.0004) and an 11‐fold increase in collagen content (1.93 vs. 0.17 mm 2 ; p = 0.005). Collagen subtype analysis revealed a shift toward active collagen within the injured larynx compared to the uninjured, with increased Type III Collagen (69.0% vs. 26.1%; p < 0.0001) and reduced Type I Collagen (27.2% vs. 73.9%; p < 0.0001) in the posterior glottis, consistent with the proliferative phase of wound healing. Collagen fiber alignment analysis demonstrated increased coherency in injured tissues (0.36 vs. 0.21; p = 0.023), indicating early organized collagen formation consistent with scar formation within the posterior glottis. Conclusions: The model offers a robust platform for studying the acute pathogenesis of laryngeal injury and for testing the treatment options in the management of ALgI. Level of Evidence: 3.
- 5 November 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (6)
Open AccessDevelopment of a Clinically Relevant Rabbit Model of Acute Laryngeal Injury
Objectives: Acute laryngeal injury (ALgI) is created as a result of endotracheal tube pressure ulcer formation leading to fibrosis and inflammation. This condition often leads to airway obstruction and voice and swallowing dysfunction. This study demonstrates a reliable animal model of ALgI to reproduce the acute wound process seen clinically, to explore the pathophysiology of this disease process, and to serve as a reproducible injury suitable for the evaluation of therapeutic interventions. Methods: An ALgI model was developed in New Zealand White rabbits using precise mucosal stripping of the posterior larynx, followed by intubation with an oversized 4.0 endotracheal tube for 1 h to mimic intubation‐associated trauma and pressure ischemia. Laryngoscopy and laryngeal harvest were performed 2 weeks post‐injury for histologic and immunofluorescent evaluation. Results: Injured rabbits demonstrated an eightfold increase in posterior glottic thickness (1.57 vs. 0.19 mm in controls; p = 0.0004) and an 11‐fold increase in collagen content (1.93 vs. 0.17 mm 2 ; p = 0.005). Collagen subtype analysis revealed a shift toward active collagen within the injured larynx compared to the uninjured, with increased Type III Collagen (69.0% vs. 26.1%; p < 0.0001) and reduced Type I Collagen (27.2% vs. 73.9%; p < 0.0001) in the posterior glottis, consistent with the proliferative phase of wound healing. Collagen fiber alignment analysis demonstrated increased coherency in injured tissues (0.36 vs. 0.21; p = 0.023), indicating early organized collagen formation consistent with scar formation within the posterior glottis. Conclusions: The model offers a robust platform for studying the acute pathogenesis of laryngeal injury and for testing the treatment options in the management of ALgI. Level of Evidence: 3.
- Open Access
Development of a Clinically Relevant Rabbit Model of Acute Laryngeal Injury
Objectives: Acute Laryngeal Injury (ALgI) is created as a result of endotracheal tube pressure ulcer formation leading to fibrosis and inflammation. This condition often leads to airway obstruction and voice and swallowing dysfunction. This study demonstrates a reliable animal model of ALgI to reproduce the acute wound process seen clinically, to explore the pathophysiology of this disease process, and serve as a reproducible injury suitable for the evaluation of therapeutic interventions. Methods: An ALgI model was developed in New Zealand White rabbits using precise mucosal stripping of the posterior larynx, followed by intubation with an oversized 4.0 endotracheal tube for one hour to mimic intubation-associated trauma and pressure ischemia. Laryngoscopy and laryngeal harvest were performed two weeks post-injury for histologic and immunofluorescent evaluation. Results: Injured rabbits demonstrated an eight-fold increase in posterior glottic thickness (1.57mm vs. 0.19mm in controls; p=0.0004) and eleven-fold increase in collagen content (1.93mm 2 vs. 0.17mm 2 ; p=0.005). Collagen subtype analysis revealed a shift toward active collagen within the injured larynx compared to the uninjured, with increased type III collagen (69.0%% vs. 26.1%; p<0.0001) and reduced type I collagen (27.2% vs. 73.9%; p<0.0001) in the posterior glottis, consistent with the proliferative phase of wound healing. Collagen fiber alignment analysis demonstrated increased coherency in injured tissues (0.36 vs. 0.21; p=0.023), indicating early organized collagen formation consistent with scar formation within the posterior glottis. Conclusions: The model offers a robust platform for studying the acute pathogenesis of laryngeal injury and for testing the treatment options in the management of ALgI. Level of Evidence: Level III
Open AccessDevelopment of a Clinically Relevant Rabbit Model of Acute Laryngeal Injury
Objectives: Acute Laryngeal Injury (ALgI) is created as a result of endotracheal tube pressure ulcer formation leading to fibrosis and inflammation. This condition often leads to airway obstruction and voice and swallowing dysfunction. This study demonstrates a reliable animal model of ALgI to reproduce the acute wound process seen clinically, to explore the pathophysiology of this disease process, and serve as a reproducible injury suitable for the evaluation of therapeutic interventions. Methods: An ALgI model was developed in New Zealand White rabbits using precise mucosal stripping of the posterior larynx, followed by intubation with an oversized 4.0 endotracheal tube for one hour to mimic intubation-associated trauma and pressure ischemia. Laryngoscopy and laryngeal harvest were performed two weeks post-injury for histologic and immunofluorescent evaluation. Results: Injured rabbits demonstrated an eight-fold increase in posterior glottic thickness (1.57mm vs. 0.19mm in controls; p=0.0004) and eleven-fold increase in collagen content (1.93mm 2 vs. 0.17mm 2 ; p=0.005). Collagen subtype analysis revealed a shift toward active collagen within the injured larynx compared to the uninjured, with increased type III collagen (69.0%% vs. 26.1%; p<0.0001) and reduced type I collagen (27.2% vs. 73.9%; p<0.0001) in the posterior glottis, consistent with the proliferative phase of wound healing. Collagen fiber alignment analysis demonstrated increased coherency in injured tissues (0.36 vs. 0.21; p=0.023), indicating early organized collagen formation consistent with scar formation within the posterior glottis. Conclusions: The model offers a robust platform for studying the acute pathogenesis of laryngeal injury and for testing the treatment options in the management of ALgI. Level of Evidence: Level III
- 26 March 2025
Decision Making in the Managment of Laryngopharyngeal Reflux Disease: Antacids, Alginates, and the Role of Diet.
Laryngopharyngeal reflux and gastroesophageal reflux disease, have significant impact on quality of life and health care costs. Antacids, alginates, and diet modifications are non-prescription interventions that can help to manage these conditions with limited risk of side-effects. Alginates have emerged as a unique mechanism of treatment to block reflux episodes. When combined with dietary interventions that target reflux triggers, alginates demonstrate enhanced efficacy in managing symptoms and promoting mucosal healing. This article explores the role of antacids, alginates, and diet in reflux management, focusing on their combined impact on symptom relief, patient outcomes, and long-term management strategies.
- 26 March 2025
Decision Making in the Managment of Laryngopharyngeal Reflux Disease: Antacids, Alginates, and the Role of Diet.
Laryngopharyngeal reflux and gastroesophageal reflux disease, have significant impact on quality of life and health care costs. Antacids, alginates, and diet modifications are non-prescription interventions that can help to manage these conditions with limited risk of side-effects. Alginates have emerged as a unique mechanism of treatment to block reflux episodes. When combined with dietary interventions that target reflux triggers, alginates demonstrate enhanced efficacy in managing symptoms and promoting mucosal healing. This article explores the role of antacids, alginates, and diet in reflux management, focusing on their combined impact on symptom relief, patient outcomes, and long-term management strategies.
- 27 August 2023
- Published by Elsevier in Journal of Voice
- Vol. 40 (1) , 255.e15-255.e21
Characterizing Gender-Affirming Voice Intervention Discussion on Social Media: A Cross-Platform Analysis
- 27 August 2023
- Published by Elsevier in Journal of Voice
- Vol. 40 (1) , 255.e15-255.e21
Characterizing Gender-Affirming Voice Intervention Discussion on Social Media: A Cross-Platform Analysis
- Open Access
- 17 July 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (1) , 367-373
Voice Improvement After Essential Tremor Treatment via Focused Ultrasound and Deep Brain Stimulation
- 17 July 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (1) , 367-373
Open AccessVoice Improvement After Essential Tremor Treatment via Focused Ultrasound and Deep Brain Stimulation
- Open Access
- 16 May 2023
- Published by Wiley in The Laryngoscope
- Vol. 133 (11) , 3080-3086
Evolving Endotracheal Tube Preferences and Practices: Intensivist Knowledge Gaps and Sex Disparities
Objectives: The complex management of intubation-related laryngeal injury makes prevention vital. The purpose of this study is to assess endotracheal tube (ETT) practices and preferences among intensivists at our institution. Methods: Chart review of intubated patients and intensivist survey were simultaneously performed in January 2016 and August 2022. A height-to-ETT size ratio (H:ETT) was calculated for each patient in the 2022 cohort. Intubated patients were followed until tracheostomy, extubation, or death occurred. Surveys assessed intensivist preferences for ETT size and management of intubated patients. Results: 300 ICU patients were included. The mean ETT size for males decreased from 7.73 +/- 0.30 in 2016 to 7.57 +/- 0.25 in 2022 (p < 0.001). The average H:ETT of men was higher than females (p = 0.004), indicating that females in this population were intubated with larger ETTs relative to their height compared to males. Whereas the majority (66.7%) of intensivists endorse 7.0 ETTs as the standard for women, the majority (70%) of women at our institution are intubated with a 7.5 ETT or larger. Of intubated patients in the ICU, 23 (19.5%) were intubated for 11 days or longer. Conclusions: Compared to men, women are intubated with larger-than-preferred ETTs relative to height. Additionally, patients in our study were intubated for longer than preferred based on intensivist surveys, putting this population at higher risk for acute laryngeal injury (AlgI)-related laryngotracheal stenosis (LTS). Further studies should seek to identify similar trends and barriers to reducing ALgI-related LTS.
- 16 May 2023
- Published by Wiley in The Laryngoscope
- Vol. 133 (11) , 3080-3086
Open AccessEvolving Endotracheal Tube Preferences and Practices: Intensivist Knowledge Gaps and Sex Disparities
Objectives: The complex management of intubation-related laryngeal injury makes prevention vital. The purpose of this study is to assess endotracheal tube (ETT) practices and preferences among intensivists at our institution. Methods: Chart review of intubated patients and intensivist survey were simultaneously performed in January 2016 and August 2022. A height-to-ETT size ratio (H:ETT) was calculated for each patient in the 2022 cohort. Intubated patients were followed until tracheostomy, extubation, or death occurred. Surveys assessed intensivist preferences for ETT size and management of intubated patients. Results: 300 ICU patients were included. The mean ETT size for males decreased from 7.73 +/- 0.30 in 2016 to 7.57 +/- 0.25 in 2022 (p < 0.001). The average H:ETT of men was higher than females (p = 0.004), indicating that females in this population were intubated with larger ETTs relative to their height compared to males. Whereas the majority (66.7%) of intensivists endorse 7.0 ETTs as the standard for women, the majority (70%) of women at our institution are intubated with a 7.5 ETT or larger. Of intubated patients in the ICU, 23 (19.5%) were intubated for 11 days or longer. Conclusions: Compared to men, women are intubated with larger-than-preferred ETTs relative to height. Additionally, patients in our study were intubated for longer than preferred based on intensivist surveys, putting this population at higher risk for acute laryngeal injury (AlgI)-related laryngotracheal stenosis (LTS). Further studies should seek to identify similar trends and barriers to reducing ALgI-related LTS.